Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: Study to Treat Major Depressive Disorder (MDD) With a New Medication [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a new medication for Major Depressive Disorder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Major Depressive Disorder, Depression | Phase 2 | Status: COMPLETED | Results posted: 2019-04-16